FDA drug approval delays due to government cuts are happening but not widespread yet. Early signs and staffing challenges suggest the situation could worsen over time.

We need a streamlined approach where stakeholders can perform critical tasks — from enrollment and patient consent to prior authorization

Pharmaceutical expenditure was looked at in this study using IPD Analytics pipeline drug data as a source to predict future potential growth

Pharmaceutical expenditure was looked at in this study using IPD Analytics pipeline drug data as a source to predict future potential growth